Wedbush Reiterates Outperform Rating for AnaptysBio (NASDAQ:ANAB)
AnaptysBio (NASDAQ:ANAB – Get Free Report)‘s stock had its “outperform” rating reissued by equities research analysts at Wedbush in a research report issued on Thursday,RTT News reports. They presently have a $40.00 price objective on the biotechnology company’s stock. Wedbush’s price target points to a potential upside of 78.17% from the stock’s previous close. ANAB […]
AnaptysBio (NASDAQ:ANAB – Get Free Report)‘s stock had its “outperform” rating reissued by equities research analysts at Wedbush in a research report issued on Thursday,RTT News reports. They presently have a $40.00 price objective on the biotechnology company’s stock. Wedbush’s price target points to a potential upside of 78.17% from the stock’s previous close. ANAB […]
